| scholarly article | Q13442814 |
| P50 | author | Hartmut Jaeschke | Q88437804 |
| P2093 | author name string | Kuo Du | |
| Anwar Farhood | |||
| P2860 | cites work | Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity | Q26799194 |
| AASLD position paper: the management of acute liver failure | Q28246028 | ||
| A direct comparison of methods used to measure oxidized glutathione in biological samples: 2-vinylpyridine and N-ethylmaleimide | Q28834681 | ||
| c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity | Q33912798 | ||
| Therapeutic targeting of mitochondrial superoxide in hypertension | Q33981734 | ||
| Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) | Q34048790 | ||
| The oxygen tension modulates acetaminophen-induced mitochondrial oxidant stress and cell injury in cultured hepatocytes | Q34131871 | ||
| Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. | Q34225946 | ||
| Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine | Q34277808 | ||
| Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine | Q34294926 | ||
| Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis. | Q34299931 | ||
| The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity | Q34630779 | ||
| Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase | Q34715731 | ||
| Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity | Q35161427 | ||
| Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase. | Q35185719 | ||
| The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation | Q35858082 | ||
| Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury | Q35969312 | ||
| Time course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells. | Q36005892 | ||
| Benzyl alcohol protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes but causes mitochondrial dysfunction and cell death at higher doses | Q36404920 | ||
| Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. | Q36844150 | ||
| Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury | Q37506627 | ||
| Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury | Q37655972 | ||
| Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity | Q37656707 | ||
| Molecular mechanisms of the hepatotoxicity caused by acetaminophen | Q38027602 | ||
| Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients | Q38212434 | ||
| Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury | Q38291198 | ||
| Selective protein covalent binding and target organ toxicity | Q41387154 | ||
| Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice | Q41495452 | ||
| Lipopolysaccharide-induced mitochondrial DNA depletion | Q42730490 | ||
| Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress | Q43673027 | ||
| Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection | Q43921972 | ||
| Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? | Q43994104 | ||
| Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione | Q44186021 | ||
| Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States. | Q44492403 | ||
| Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation | Q44527209 | ||
| Acetaminophen overdose-induced liver injury in mice is mediated by peroxynitrite independently of the cyclophilin D-regulated permeability transition | Q44680186 | ||
| Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes | Q45108825 | ||
| Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress | Q45136664 | ||
| Emergency department visits for overdoses of acetaminophen-containing products | Q45706009 | ||
| Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen | Q46068587 | ||
| Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity | Q46635865 | ||
| A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria | Q46800001 | ||
| Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity | Q46974191 | ||
| Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice | Q47978001 | ||
| Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice | Q68355910 | ||
| Early loss of large genomic DNA in vivo with accumulation of Ca2+ in the nucleus during acetaminophen-induced liver injury | Q68628042 | ||
| Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol | Q68637975 | ||
| Acetaminophen overdose | Q70305728 | ||
| Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity | Q72411992 | ||
| Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8 | Q73128535 | ||
| Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice | Q77381301 | ||
| Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury | Q80077527 | ||
| Acetaminophen hepatotoxicity | Q80853377 | ||
| P433 | issue | 2 | |
| P921 | main subject | mitochondrion | Q39572 |
| paracetamol | Q57055 | ||
| hepatotoxicity | Q1349821 | ||
| P304 | page(s) | 761-773 | |
| P577 | publication date | 2016-03-22 | |
| P1433 | published in | Archives of Toxicology | Q635837 |
| P1476 | title | Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity | |
| P478 | volume | 91 |
| Q90627832 | A mitochondrial journey through acetaminophen hepatotoxicity |
| Q92231738 | Acetaminophen Hepatotoxicity |
| Q47885559 | Acetaminophen Toxicity Novel Insights into Mechanisms and Future Perspectives |
| Q92862541 | Allium Jesdianum Extract Improve Acetaminophen-Induced Hepatic Failure through Inhibition of Oxidative/Nitrosative Stress |
| Q90097440 | Animal models of drug-induced liver injury |
| Q104694481 | Assessment of the Biochemical Pathways for Acetaminophen Toxicity: Implications for its Carcinogenic Hazard Potential |
| Q46269173 | Biochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms |
| Q91596768 | Cell-permeable succinate prodrugs rescue mitochondrial respiration in cellular models of acute acetaminophen overdose |
| Q60912532 | Corilagin alleviates acetaminophen-induced hepatotoxicity via enhancing the AMPK/GSK3β-Nrf2 signaling pathway |
| Q92999694 | Ctt1 catalase activity potentiates antifungal azoles in the emerging opportunistic pathogen Saccharomyces cerevisiae |
| Q96953977 | Does JNK Regulate Acetaminophen Hepatotoxicity by Modulating Nrf2-dependent Genes or Mitochondrial Oxidant Stress? |
| Q39452662 | Editor's Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction. |
| Q92213570 | Emerging novel therapies against paracetamol (acetaminophen) hepatotoxicity |
| Q64298462 | Highlight report: Role of the ATP-releasing Panx channels in liver fibrosis |
| Q47796568 | Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity |
| Q93053142 | Inhibition of Mitochondrial ROS by MitoQ Alleviates White Matter Injury and Improves Outcomes after Intracerebral Haemorrhage in Mice |
| Q90618229 | Late Protective Effect of Netrin-1 in the Murine Acetaminophen Hepatotoxicity Model |
| Q52599702 | Licochalcone A Upregulates Nrf2 Antioxidant Pathway and Thereby Alleviates Acetaminophen-Induced Hepatotoxicity. |
| Q90600105 | Mechanisms of Inflammatory Liver Injury and Drug-Induced Hepatotoxicity |
| Q33848167 | Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology |
| Q55407513 | Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. |
| Q57461348 | Mito-tempo protects against acute liver injury but induces limited secondary apoptosis during the late phase of acetaminophen hepatotoxicity |
| Q97525891 | Mitochondrial Damage and Biogenesis in Acetaminophen-induced Liver Injury |
| Q92377698 | Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives |
| Q55092510 | Mitochondrial-Lysosomal Axis in Acetaminophen Hepatotoxicity. |
| Q93129152 | NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuries |
| Q45932834 | New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases. |
| Q94023832 | Oxidant Stress and Lipid Peroxidation in Acetaminophen Hepatotoxicity |
| Q87686282 | Oxidative Stress and Acute Hepatic Injury |
| Q28077959 | Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential |
| Q60948762 | Parathyroid Hormone Causes Endothelial Dysfunction by Inducing Mitochondrial ROS and Specific Oxidative Signal Transduction Modifications |
| Q90214018 | TGF-β/SMAD4 mediated UCP2 downregulation contributes to Aspergillus protease-induced inflammation in primary bronchial epithelial cells |
| Q89487254 | Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases |
| Q41347692 | Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy |
| Q92705157 | Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress |
| Q88083201 | Treatment of acetaminophen-induced liver injury with exogenous mitochondria in mice |
| Q42516008 | miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 2 Subfamily A Member 2 and E Member 1 Expression |
Search more.